Drug to treat agitation in Alzheimer’s patients approved in Canada
Health Canada has approved an oral drug to treat symptoms of agitation associated with dementia due to Alzheimer’s disease in patients.
Health Canada has approved an oral drug to treat symptoms of agitation associated with dementia due to Alzheimer’s disease in patients.
